BioAge Labs, Inc.
BIOA
$4.51
-$0.10-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.77% | 0.49% | -0.82% | -60.05% | 20.98% |
| Total Depreciation and Amortization | 18.37% | 12.12% | 14.63% | -20.83% | 22.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.86% | 54.00% | -70.05% | -60.04% | -64.95% |
| Change in Net Operating Assets | 54.61% | -60.26% | 199.96% | 382.65% | -418.53% |
| Cash from Operations | -26.54% | -10.79% | 39.57% | -92.34% | -42.24% |
| Capital Expenditure | -354.29% | -- | -- | -208.08% | 37.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -44,588.57% | -- | -- | -208.08% | 37.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -50.00% | -- | -- |
| Issuance of Common Stock | -- | -- | 691,050.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -9,469.23% | -5,950.00% | -32,625.00% |
| Cash from Financing | 37.16% | -100.89% | 2,567.99% | 454,107.14% | -119.10% |
| Foreign Exchange rate Adjustments | -170.59% | -163.16% | 310.77% | -265.71% | -140.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.93% | -163.58% | 307.53% | 2,328.86% | -1,413.63% |